News

Updates from VUS Genetics — company news, events, and publications.

News & press releases

Latest from VUS Genetics

Press Release·June 9, 2026
VUS Genetics Strengthens Board with Niall Martin and Eric Lindquist
Two strategic board appointments and an exclusive license to geneSlice^™ signal a pivotal moment for the company.Read more
Press Release·May 28, 2026
SickKids and VUS Genetics Announce geneSlice^™ Collaboration
Exclusive license of geneSlice^™ supports ongoing efforts to improve how genomic data informs care decisions.Read more

Events

Where to find us

TechBBQ 2026
August 26–27, 2026 — Bella Center, Copenhagen, Denmark
Europe's leading tech event for founders, bringing together startups, investors, and industry across keynotes, panels, and dedicated life science and deep tech tracks.Event site
RESI Boston 2026
September 22–23, 2026 — The Westin Copley Place, Boston, USA
Redefining Early Stage Investments partnering conference, part of Biotech Week Boston, matching early stage life science companies with investors and strategic partners through targeted one-on-one meetings.Event site
1st Annual European Healthcare Impact Summit
October 6, 2026 — Mövenpick Hotel, Basel, Switzerland
Sachs Associates summit gathering pharma, medtech, diagnostics, and digital health leaders with investors for company presentations, keynotes, and partnering across the healthcare innovation landscape.Event site
26th Annual Biotech in Europe Forum
October 7–8, 2026 — Mövenpick Hotel, Basel, Switzerland
Established European partnering and investment forum bringing together 650+ delegates from pharma, biotech, and the investment community, with company presentations and one-on-one meetings.Event site
ESMO Congress 2026
October 23–27, 2026 — IFEMA, Madrid, Spain
The European Society for Medical Oncology annual congress, presenting practice-changing oncology data across precision medicine, immuno-oncology, and novel therapeutics.Event site
Clinical Cancer Genomics Conference 2026
November 3, 2026 — 20 Water Street, Canary Wharf, London, UK
Genomics England conference bringing together clinicians, researchers, scientists and healthcare professionals from across Europe to share advances in clinical cancer genomics and how genomics is transforming cancer diagnosis, treatment and patient care.Event site
38th EORTC-NCI-AACR Symposium (ENA)
November 18–20, 2026 — CCIB, Barcelona, Spain
Leading forum on molecular targets and cancer therapeutics, spotlighting preclinical and phase I studies in drug development and translational research.Event site

Past events

bio:cap europe
June 9–11, 2026 — CityCube, Messe Berlin, Germany
International Life Science and AI Investival connecting global investors, founders, and industry leaders through keynotes, curated matchmaking, and pitch opportunities.Event site
Dutch Biotech Event 2026
June 12, 2026 — InnStyle, Maarssen, Netherlands
Annual gathering for biotech professionals featuring keynote speakers who bridge life sciences and entrepreneurship, with interactive workshops and networking.Event site

Publications

Selected publications

From our team and advisors — demonstrating the variant-classification approach our platform builds on.

Team publications

Mathis N, Allam A, Tálas A, …, Schep R, …, Schwank G.
Machine learning prediction of prime editing efficiency across diverse chromatin contexts.
Nat Biotechnol. 2025;43(5):712–719.PMID: 38907037
Schep R, Trauernicht M, Vergara X, …, van Steensel B.
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing.
Nucleic Acids Res. 2024;52(15):8815–8832.PMID: 38953163
van Gemert F, Drakaki A, Morales Lozano I, …, Te Riele H.
ADARp150 counteracts whole genome duplication.
Nucleic Acids Res. 2024;52(17):10370–10384.PMID: 39189458
Muniesa-Vargas A, Davó-Martínez C, Ribeiro-Silva C, et al.
Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure.
Nat Commun. 2024.PMID: 38664429
Schep R, Brinkman EK, Leemans C, …, van Steensel B.
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance.
Mol Cell. 2021;81(10):2216–2230.PMID: 33848455

Foundational work

Earlier methodological work from team members and founders that pre-dates the geneSlice^™ platform but demonstrates the variant-classification approach.

Ivakine et al, 2022.
Saturation mutagenesis of NPC1 and BRCA2 for functional variant classification.
PMID: 35190686
Pettitt et al, 2018.
Mutational scanning for compound–target interaction in DDR drug development.
PMID: 29748565